Docket #: S20-225
Automated Point-of-Care Nucleic Acid Amplification Test
Stanford researchers have developed an automated point-of-care nucleic acid amplification test for use in clinics, pharmacies or even at home. While these tests are standard for detection of diseases like influenza and Covid-19, they currently require lab facilities and specialized technicians. This new system can perform quantitative multiplex nucleic acid detection without specialized training. This is due to the digitally controlled fluidic system that automatically washes and injects reagents, combined with the on-chip temperature management system for polymerase chain reactions (PCR) and portable magnetoresistive sensor platform.
Stage of Research
Applications
- Point-of-care diagnostics: clinics, pharmacies, home
- Customizable to target disease
- Research tool
Advantages
- Increased sensitivity over existing point-of-care diagnostics
- Multiplex detections without specialized training
Related Links
Similar Technologies
-
RUSPseq- Multiplex Gene Sequencing from Ultra-Low Amounts of DNA with Rapid COVID Applications S19-021RUSPseq- Multiplex Gene Sequencing from Ultra-Low Amounts of DNA with Rapid COVID Applications
-
Biomarkers for predicting severe outcome in patients with infection S20-396Biomarkers for predicting severe outcome in patients with infection
-
Polysaccharide Hydrogel Optical Fibers for Biomedical Applications S21-071Polysaccharide Hydrogel Optical Fibers for Biomedical Applications